https://orcid.org/0000-0002-2502-3431
Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Francesco Paolo Bianchi, Pasquale Stefanizzi, Giovanni Migliore, Andrea Martinelli, Luigi Vimercati, Cinzia Annatea Germinario & Silvio Tafuri. (2023) Prevalence of healthcare workers fully vaccinated against hepatitis B without circulating antibodies in Italy and role of age at baseline cycle vaccination: a systematic review and meta-analysis. Expert Review of Vaccines 22:1, pages 139-147.
Read now
Read now
Articles from other publishers (16)
Anna A. Khamidulina, Irina L. Solovеva, Mikhail P. Kostinov, Valentina B. Polishchuk, Natalia V. Firsova, Atabeg B. Achilov, Tatiana N. Nikitina, Darya A. Isayeva, Darya D. Petrunina, Ksenia M. Korotkova, Yekaterina А. Gerlinger & Naida A. Magomedova. (2024) Evaluation of Post-Vaccination Immunity in Children and Adolescents after Viral Hepatitis B Vaccine. Pediatric pharmacology 21:1, pages 24-31.
Crossref
Crossref
Mohammad Enamul Hoque Kayesh, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2023) Effects of neddylation on viral infection: an overview. Archives of Virology 169:1.
Crossref
Crossref
Jun Wang, Yong-guo Huang, Ye Zeng, Qin-zhen Cai, Mo Wu, Xin Shen, Wen-bin Tuo, Si Xie, Xiang Ma, Yun Xiang, Chun-hui Yuan & Cong Yao. (2023) Epidemiological and clinical profile of pediatric hepatitis B virus infections in Wuhan: a retrospective cohort study. BMC Pediatrics 23:1.
Crossref
Crossref
Tommaso Stroffolini & Giacomo Stroffolini. (2023) Vaccination Campaign against Hepatitis B Virus in Italy: A History of Successful Achievements. Vaccines 11:10, pages 1531.
Crossref
Crossref
Marco Fonzo, Chiara Bertoncello & Andrea Trevisan. (2022) Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination. npj Vaccines 7:1.
Crossref
Crossref
Alborz Rahmani, Alfredo Montecucco, Bruno Kusznir Vitturi, Nicoletta Debarbieri, Guglielmo Dini & Paolo Durando. (2022) Long-Term Effectiveness of Hepatitis B Vaccination in the Protection of Healthcare Students in Highly Developed Countries: A Systematic Review and Meta-Analysis. Vaccines 10:11, pages 1841.
Crossref
Crossref
Mohammad Enamul Hoque Kayesh, Md Abul Hashem, Takahiro Sanada, Bouchra Kitab, Md Haroon Or Rashid, Lipi Akter, Sayeh Ezzikouri, Shuko Murakami, Shintaro Ogawa, Yasuhito Tanaka, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2022) Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model. Frontiers in Virology 2.
Crossref
Crossref
Mohammad Enamul Hoque Kayesh, Md Abul Hashem, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2022) In vivo Delivery Tools for Clustered Regularly Interspaced Short Palindromic Repeat/Associated Protein 9-Mediated Inhibition of Hepatitis B Virus Infection: An Update. Frontiers in Microbiology 13.
Crossref
Crossref
Angga Dwiartama, Wahyu Fadzilla Nirbayati, Ernawati Arifin Giri-Rachman, Wardono Niloperbowo, Marselina Irasonia Tan & Anindyajati Anin. (2022) Knowledge, Attitude, and Practice towards Hepatitis B Infection Prevention and Screening among Indonesians. International Journal of Environmental Research and Public Health 19:8, pages 4644.
Crossref
Crossref
Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill & Shishir Shetty. (2022) Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma. Cancers 14:5, pages 1255.
Crossref
Crossref
Rong-Nan Chien & Yun-Fan Liaw. (2022) Current Trend in Antiviral Therapy for Chronic Hepatitis B. Viruses 14:2, pages 434.
Crossref
Crossref
Rahila Zannat Sadiea, Shahnaj Sultana, Bijan Mohon Chaki, Tasnim Islam, Sharmy Dash, Sharmin Akter, Md Sayeedul Islam, Taheruzzaman Kazi, Abir Nagata, Rocco Spagnuolo, Rosellina Margherita Mancina & Md Golzar Hossain. (2022) Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches. International Journal of Molecular Sciences 23:3, pages 1617.
Crossref
Crossref
Tommaso Stroffolini, Filomena Morisco, Luigina Ferrigno, Giuseppina Pontillo, Giuseppina Iantosca, Valentina Cossiga, Simonetta Crateri, Maria Tosti & the SEIEVA Collaborating Group. (2022) Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country. Viruses 14:2, pages 245.
Crossref
Crossref
Hiroyuki Amano, Tatsuo Kanda, Hitoshi Mochizuki, Yuichiro Kojima, Yoji Suzuki, Kenji Hosoda, Hiroshi Ashizawa, Yuko Miura, Shotaro Tsunoda, Yosuke Hirotsu, Hiroshi Ohyama, Naoya Kato, Mitsuhiko Moriyama, Shuntaro Obi & Masao Omata. (2021) The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection. Viruses 13:11, pages 2216.
Crossref
Crossref
Mohammad Enamul Hoque Kayesh, Michinori Kohara & Kyoko Tsukiyama-Kohara. (2021) Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview. International Journal of Molecular Sciences 22:19, pages 10462.
Crossref
Crossref
Masataka Tsuge. (2021) Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?. Viruses 13:10, pages 1920.
Crossref
Crossref